|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:MYO1D-WAPAL (FusionGDB2 ID:56665) |
Fusion Gene Summary for MYO1D-WAPAL |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: MYO1D-WAPAL | Fusion gene ID: 56665 | Hgene | Tgene | Gene symbol | MYO1D | WAPAL | Gene ID | 4642 | 23063 |
| Gene name | myosin ID | WAPL cohesin release factor | |
| Synonyms | PPP1R108|myr4 | FOE|KIAA0261|WAPAL | |
| Cytomap | 17q11.2 | 10q23.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | unconventional myosin-Idmyosin-I gammaprotein phosphatase 1, regulatory subunit 108 | wings apart-like protein homologfriend of EBNA2 (Epstein-Barr virus nuclear protein 2)friend of EBNA2 protein | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | O94832 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000318217, ENST00000394649, ENST00000579584, ENST00000584232, ENST00000583621, | ENST00000263070, ENST00000372075, ENST00000484070, ENST00000298767, | |
| Fusion gene scores | * DoF score | 24 X 17 X 12=4896 | 4 X 3 X 4=48 |
| # samples | 28 | 5 | |
| ** MAII score | log2(28/4896*10)=-4.12810482574769 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/48*10)=0.0588936890535686 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: MYO1D [Title/Abstract] AND WAPAL [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | MYO1D(31065270)-WAPAL(88233730), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | MYO1D-WAPAL seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | MYO1D | GO:0010923 | negative regulation of phosphatase activity | 19389623 |
| Fusion gene breakpoints across MYO1D (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across WAPAL (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | ESCA | TCGA-JY-A6F8 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
Top |
Fusion Gene ORF analysis for MYO1D-WAPAL |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000318217 | ENST00000263070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000318217 | ENST00000372075 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000318217 | ENST00000484070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000394649 | ENST00000263070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000394649 | ENST00000372075 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000394649 | ENST00000484070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000579584 | ENST00000263070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000579584 | ENST00000372075 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5CDS-intron | ENST00000579584 | ENST00000484070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5UTR-3CDS | ENST00000584232 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5UTR-intron | ENST00000584232 | ENST00000263070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5UTR-intron | ENST00000584232 | ENST00000372075 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| 5UTR-intron | ENST00000584232 | ENST00000484070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| Frame-shift | ENST00000394649 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| In-frame | ENST00000318217 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| In-frame | ENST00000579584 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| intron-3CDS | ENST00000583621 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| intron-intron | ENST00000583621 | ENST00000263070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| intron-intron | ENST00000583621 | ENST00000372075 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| intron-intron | ENST00000583621 | ENST00000484070 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000318217 | MYO1D | chr17 | 31065270 | - | ENST00000298767 | WAPAL | chr10 | 88233730 | - | 6267 | 2051 | 284 | 3979 | 1231 |
| ENST00000579584 | MYO1D | chr17 | 31065270 | - | ENST00000298767 | WAPAL | chr10 | 88233730 | - | 6234 | 2018 | 251 | 3946 | 1231 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000318217 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - | 0.000452526 | 0.9995474 |
| ENST00000579584 | ENST00000298767 | MYO1D | chr17 | 31065270 | - | WAPAL | chr10 | 88233730 | - | 0.00042458 | 0.99957544 |
Top |
Fusion Genomic Features for MYO1D-WAPAL |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for MYO1D-WAPAL |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:31065270/chr10:88233730) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| MYO1D | . |
| FUNCTION: Unconventional myosin that functions as actin-based motor protein with ATPase activity (By similarity). Plays a role in endosomal protein trafficking, and especially in the transfer of cargo proteins from early to recycling endosomes (By similarity). Required for normal planar cell polarity in ciliated tracheal cells, for normal rotational polarity of cilia, and for coordinated, unidirectional ciliary movement in the trachea. Required for normal, polarized cilia organization in brain ependymal epithelial cells (By similarity). {ECO:0000250|UniProtKB:F1PRN2, ECO:0000250|UniProtKB:Q63357}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 102_109 | 582 | 1007.0 | Nucleotide binding | ATP |
| Tgene | WAPAL | chr17:31065270 | chr10:88233730 | ENST00000298767 | 3 | 19 | 749_782 | 548 | 1191.0 | Coiled coil | Ontology_term=ECO:0000255 | |
| Tgene | WAPAL | chr17:31065270 | chr10:88233730 | ENST00000298767 | 3 | 19 | 626_1169 | 548 | 1191.0 | Domain | WAPL |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 699_719 | 582 | 1007.0 | Domain | IQ 1 |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 721_741 | 582 | 1007.0 | Domain | IQ 2 |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 812_1005 | 582 | 1007.0 | Domain | TH1 |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 9_695 | 582 | 1007.0 | Domain | Myosin motor |
| Hgene | MYO1D | chr17:31065270 | chr10:88233730 | ENST00000318217 | - | 14 | 22 | 572_594 | 582 | 1007.0 | Region | Actin-binding |
| Tgene | WAPAL | chr17:31065270 | chr10:88233730 | ENST00000298767 | 3 | 19 | 260_286 | 548 | 1191.0 | Coiled coil | Ontology_term=ECO:0000255 |
Top |
Fusion Gene Sequence for MYO1D-WAPAL |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >56665_56665_1_MYO1D-WAPAL_MYO1D_chr17_31065270_ENST00000318217_WAPAL_chr10_88233730_ENST00000298767_length(transcript)=6267nt_BP=2051nt AGGCTGGAGGCGGGACCAGCCGCTGCCGTCTCCGTCTCGGTGTCCCGGCCCCTACAGCGCCCGGCAGCCGCGGCGGGAGGAGCGGAAACT GTCGGGTGCGTCCCGTTCGGAGCCGCGCCGGCCGAGAAGGCGCCGAGGAGCAGCGAGGCGGCCTCTGTCCGGCCCGGACCCGCCGAGCGG CGTGCGCGCCCCCTCCCCGTAGCCTCGCGGCGCGGCCTCGCCCCGGCCCCTCCCGAGCTCATCGCGGGCCCACGGAGCGGCCCCGGAGGC CCGAGCGCGCCCACCTGAGCCCCCGCGCTGGCGCCATGGCGGAGCAGGAGAGCCTGGAATTCGGCAAGGCAGACTTCGTGCTGATGGACA CCGTCTCCATGCCCGAGTTCATGGCCAACCTCAGGCTCAGATTTGAAAAAGGGCGCATCTATACGTTCATTGGAGAAGTCGTCGTTTCTG TGAACCCTTACAAGTTGTTGAACATCTATGGAAGAGACACAATTGAGCAGTATAAAGGCCGTGAGCTGTATGAGAGACCGCCTCACCTTT TTGCTATTGCGGATGCTGCTTACAAGGCTATGAAGAGGCGATCAAAAGACACTTGTATTGTGATATCAGGGGAAAGTGGAGCTGGTAAAA CGGAAGCCAGTAAGTACATTATGCAGTATATTGCGGCCATCACCAACCCCAGTCAGAGAGCAGAGGTTGAAAGAGTGAAGAATATGTTGC TTAAGTCCAACTGTGTTTTGGAAGCTTTTGGAAATGCCAAAACCAACCGTAATGACAACTCAAGCAGGTTTGGAAAATACATGGATATCA ACTTTGACTTCAAGGGTGACCCTATTGGTGGGCATATCAATAACTACTTACTAGAAAAGTCTCGAGTGATTGTGCAACAGCCAGGAGAAA GAAGCTTTCATTCTTTCTATCAGCTACTCCAAGGAGGTTCAGAACAAATGCTACGCTCTCTACATCTCCAGAAATCCCTTTCATCCTACA ACTATATTCATGTGGGAGCTCAATTAAAGTCTTCTATCAATGATGCTGCCGAATTCAGAGTTGTTGCTGATGCCATGAAAGTCATTGGCT TCAAACCTGAGGAGATCCAAACAGTGTATAAGATTTTGGCTGCTATTCTGCACTTGGGAAATTTAAAATTTGTAGTAGATGGTGACACGC CTCTTATTGAGAATGGCAAAGTAGTATCTATCATAGCAGAATTGCTCTCTACTAAGACAGATATGGTTGAGAAAGCCCTTCTTTACCGGA CTGTGGCCACAGGCCGTGACATCATTGACAAGCAGCACACAGAACAAGAGGCCAGCTACGGCAGAGACGCCTTTGCCAAGGCAATATATG AGCGCCTTTTTTGTTGGATCGTTACTCGCATCAATGATATTATTGAGGTCAAGAACTATGACACCACAATCCATGGGAAAAACACTGTTA TTGGTGTCTTGGATATCTATGGCTTTGAAATCTTTGACAACAACAGTTTTGAACAATTCTGTATCAATTACTGCAATGAGAAACTGCAGC AGCTATTTATTCAGCTGGTTCTGAAGCAAGAACAAGAGGAATACCAGCGGGAAGGGATCCCCTGGAAACATATTGACTACTTCAACAATC AGATCATTGTTGACCTCGTGGAGCAACAGCACAAAGGGATCATTGCAATCCTTGATGATGCTTGCATGAATGTCGGCAAAGTCACCGATG AAATGTTTCTTGAAGCACTTAACAGTAAATTGGGCAAACACGCCCATTTTTCCAGCCGAAAGCTCTGTGCCTCAGACAAAATTCTGGAGT TTGATCGAGATTTTCGAATTCGACATTATGCAGGCGATGTAGTCTATTCTGTCATTGGTTTTATTGACAAAAATAAAGATACTTTATTTC AAGATTTCAAGCGCCTTATGTATAACAGTTCAAATCCTGTGCTCAAGAATATGTGGCCTGAAGGCAAACTGAGCATTACAGAGGTGACCA AGCGACCTCTGACTGCTGCTACCTTGTTTAAGAATTCTATGATTGCTCTAGTAGACAACCTTGCATCAAAGTCACCCACAAAAGCTGTAT ATAATGCCAGACATTGGAATCATCCAGATTCAGAAGAACTGCCTGGGCCACCAGTAGTAAAACCTCAGAGTGTCACAGTGAGGCTGTCTT CAAAGGAACCAAATCAAAAAGATGATGGAGTTTTTAAGGCTCCTGCACCACCATCCAAAGTGATAAAAACTGTGACAATACCTACTCAGC CCTACCAAGATATAGTTACTGCACTGAAATGCAGACGAGAAGACAAAGAATTATATACTGTTGTTCAGCACGTGAAGCACTTCAACGATG TTGTAGAATTTGGTGAAAATCAAGAGTTCACTGATGACATTGAGTACTTGTTAAGTGGCTTAAAGAGCACTCAGCCTCTAAACACACGTT GCCTTAGTGTTATTAGCTTGGCTACTAAATGTGCCATGCCCAGTTTTCGAATGCACCTGAGAGCACATGGGATGGTAGCAATGGTCTTTA AAACCTTGGATGATTCCCAGCACCATCAGAATCTGTCCCTCTGTACAGCTGCCCTCATGTATATACTGAGTAGAGATCGTTTGAACATGG ATCTTGATAGAGCTAGCTTAGATCTAATGATTCGACTTTTGGAACTGGAACAAGATGCTTCATCAGCCAAGCTACTGAATGAAAAAGACA TGAACAAAATTAAAGAAAAAATCCGAAGGCTCTGTGAAACTGTACACAACAAGCATCTTGATCTAGAAAATATAACGACTGGGCATTTAG CTATGGAGACATTATTATCCCTTACTTCTAAACGAGCAGGAGACTGGTTTAAAGAAGAACTCCGGCTTTTGGGTGGTCTGGATCATATTG TAGATAAAGTAAAAGAATGTGTGGATCATTTAAGTAGAGATGAGGATGAAGAGAAACTGGTAGCCTCACTATGGGGAGCAGAGAGATGTT TACGAGTTTTAGAAAGTGTAACTGTGCATAATCCCGAAAATCAAAGCTACTTGATAGCATATAAAGATTCCCAACTTATTGTTTCATCAG CTAAAGCATTACAGCATTGTGAAGAACTGATTCAGCAGTACAACCGTGCTGAGGACAGCATATGCTTAGCTGACAGTAAGCCTCTGCCTC ACCAGAATGTAACTAACCATGTAGGCAAAGCAGTGGAGGACTGCATGAGGGCCATCATCGGGGTGTTGCTTAATTTAACTAATGATAATG AGTGGGGCAGCACCAAAACAGGAGAGCAGGACGGTCTCATAGGCACAGCGCTGAACTGTGTGCTTCAGGTTCCAAAGTACCTACCTCAGG AGCAGAGATTTGATATTCGAGTGCTGGGCTTAGGTCTGCTGATAAATCTAGTGGAGTATAGTGCTCGGAATCGGCACTGTCTTGTCAACA TGGAAACATCGTGCTCTTTTGATTCTTCCATCTGTAGTGGAGAAGGGGATGATAGTTTAAGGATAGGTGGACAAGTTCATGCTGTCCAGG CTTTAGTGCAGCTATTCCTTGAGCGAGAGCGGGCAGCCCAGCTAGCAGAAAGTAAAACAGATGAGTTGATCAAAGATGCTCCCACCACTC AGCATGATAAGAGTGGAGAGTGGCAAGAAACAAGTGGAGAAATACAGTGGGTGTCAACTGAAAAGACTGATGGTACAGAAGAGAAACATA AGAAGGAGGAGGAGGATGAAGAACTTGACCTCAATAAAGCCCTTCAGCATGCCGGCAAACACATGGAGGATTGCATTGTGGCCTCCTACA CAGCACTACTTCTTGGGTGTCTCTGCCAGGAAAGTCCAATCAATGTAACCACTGTGCGGGAATATCTGCCAGAAGGAGACTTTTCAATAA TGACAGAGATGCTCAAAAAATTTTTGAGTTTTATGAATCTCACTTGTGCTGTTGGAACAACTGGCCAGAAATCTATCTCTAGAGTGATTG AATATTTGGAACATTGCTAGCTGCTTTACCTTTGCTTCAGGTGCTCGGTAATGCTGGAGCTATCCTTAGACAAAGAAAAGTCAAGTCATG AAAGAAGTCCTTGAAGATATACCAAGAACATTCATCAGTATCATTCGTGTTTGGATTTTTAAGGCCACCTGATTTCTTCGTCATGCATTC GGCATTTGCTAAATGACAGTTACTACATCAATCTGCAACTATCAAAAATGAGGGGAAAAGGTTCAGGCTGTTAACAATTCCATGCAGTAT TTAAATACATTTACTTTGGCAGAGTTTATACCCTCCCCTTGTTTTCTTGCTTTATTCTGGGCAAGTTTGAAGGGGAAAATTTGTGCTGCT GTTAGTGCAACTGCTGTGTATGTTGAGCCACTGTTGTCATGCCAGCCAGGTGCAAAGGCAGCTTAGCTACTGAGGTAGCGAATGTTCTGA GGACATTCTAGACAACAGCTTAGTTCCTTTTTCAGGCTCATTTGCTTTTGCTTTTTTGTTGAATGATTCCAATCGTAAATAAAGCTTTTA ATAATTTTGTGAATTTTTTGGTTGTTGTTCCCTGAACTACTGTCTATATTTAAAATTAGATGGAATCCAAAGATACACGGGATTAATAGT ATATTTTTTTATTCTTGATTAGGTTTGGGTTATTGAACTATTTTTTACTTTTGAGACCACAACCATATTCAATATCATACCATAATGTGT CATAGCTATAGGCACAAGAAAAACAACAGTTTGAGAGAATATTATATAAGATGATGTGCCCTGTTAAAAGGAGGAGGCAAAATAGTCAAA CCCAGGGTAGTTTACACTTAATGCTAGGGAGGCTCTTAAAACATTATTAGATTTTGAGGAAAGACTCTCTAGATATATTTTCTAATGTTC AGTACAATAAATATAAGGAAGCTAAAACACCAATGTGGAATTCCTGTTTCCAGATAACATGTATATTCTTCTATAGAGTGACAGGATCAA TTGCATAAGCGCAAAGCCTTAAATTGCTGGTTTAGAGAAGACCCTTTTTTCATTCAGATTCTTTGTTCGTAGAGCAGTTATTTGAAAAAC AGTTATGGAACACAAAACATTTTATAGATTTAATATCATAACATTGCAAATTTTTCTTGTATTATTCACACCACTGGTTATACTTTTTTT TTTCCTTTTTTATTGATTGGGCCTGAATACAGGCTTTCTAGAGATCTTTTTCATTAATACTTTTAAATACCTTTCAGGTAGTTACATCAT GTTTCTTCATTGGATTTGTAAAACTTGAAGCCATAAAAATATTAGTTTGGTGTGTATTGGGGAAAATAGCTAAAAGTCTAATTTTTACCC ATTTAGACTTTGTTATTTCCTTGTATAAAGTGACAAATCGGGGCTCTTGTATCAGTGCCAGCTGTAATGTTTTTAAATGCAGTGGCTGCC TTCTATTGTCTTCCTATTTTTGATAATGCAGATTGTTGGGAAATCTGTAAGGAAGTAACTGATTCCAGGCAAATTGTTTTCTTCCTTCTA CCCACCCCAACCCCTACCCATCACCTTTTAAGAACATAGTACGCCAGTGTAACGTGGGAACCATTGAGATTGTATTTGCCCTGAGTATTA AAGCTAGCTTAGCAAAATACTTTTAAAAACATATTGGTAAATGATACCCGTAAAATTAAATTAGTTATATTTTATTTTAAAATGCAAAAT ACATTGATATTTATTAATCATTGGATTTAGGGAAAGGGACAGATTTTTGGTGAACCTGACTTGTGGCAGATGGTAAGGAATATTATAAAA CATTTGGATGAGAACAATCAGGGCGAACTGCATTTTTCTGTTACACTGGTAATCATTTGAAAATTGATTTACCTCAGTGTTTAACAGTTT TTTGTTTTGTTTTGTTTTTTAAATAATAACTAATTGTCGAGCACTGATAGAGATGCAGATTTTGGTGGGGGGAGGTGGTGGGGGAGATAA TCACTTCACCAACTGCAGTGCATTTGTGTGTTTTTAACCCTCAGAGAACTCTGCATTTTAGGGTACTTGAGGCTGACTTAACTAAAAGTT TTAAAGTAACCTTTTTTCCATTGTAAATATTTCTGTAAATACTACCAATTGGAAATTAGAACAGTAGAGTACTTTTCTGAATCCAATCCT ATTTTTATTTTATACAGTATTTCTCAGCTGTGATCTTTGGAGCAAAAGCCAACGGCAGGAAAAAATAGTTTGTACCAGTTTCATGAAGTA >56665_56665_1_MYO1D-WAPAL_MYO1D_chr17_31065270_ENST00000318217_WAPAL_chr10_88233730_ENST00000298767_length(amino acids)=1231AA_BP=589 MSPRAGAMAEQESLEFGKADFVLMDTVSMPEFMANLRLRFEKGRIYTFIGEVVVSVNPYKLLNIYGRDTIEQYKGRELYERPPHLFAIAD AAYKAMKRRSKDTCIVISGESGAGKTEASKYIMQYIAAITNPSQRAEVERVKNMLLKSNCVLEAFGNAKTNRNDNSSRFGKYMDINFDFK GDPIGGHINNYLLEKSRVIVQQPGERSFHSFYQLLQGGSEQMLRSLHLQKSLSSYNYIHVGAQLKSSINDAAEFRVVADAMKVIGFKPEE IQTVYKILAAILHLGNLKFVVDGDTPLIENGKVVSIIAELLSTKTDMVEKALLYRTVATGRDIIDKQHTEQEASYGRDAFAKAIYERLFC WIVTRINDIIEVKNYDTTIHGKNTVIGVLDIYGFEIFDNNSFEQFCINYCNEKLQQLFIQLVLKQEQEEYQREGIPWKHIDYFNNQIIVD LVEQQHKGIIAILDDACMNVGKVTDEMFLEALNSKLGKHAHFSSRKLCASDKILEFDRDFRIRHYAGDVVYSVIGFIDKNKDTLFQDFKR LMYNSSNPVLKNMWPEGKLSITEVTKRPLTAATLFKNSMIALVDNLASKSPTKAVYNARHWNHPDSEELPGPPVVKPQSVTVRLSSKEPN QKDDGVFKAPAPPSKVIKTVTIPTQPYQDIVTALKCRREDKELYTVVQHVKHFNDVVEFGENQEFTDDIEYLLSGLKSTQPLNTRCLSVI SLATKCAMPSFRMHLRAHGMVAMVFKTLDDSQHHQNLSLCTAALMYILSRDRLNMDLDRASLDLMIRLLELEQDASSAKLLNEKDMNKIK EKIRRLCETVHNKHLDLENITTGHLAMETLLSLTSKRAGDWFKEELRLLGGLDHIVDKVKECVDHLSRDEDEEKLVASLWGAERCLRVLE SVTVHNPENQSYLIAYKDSQLIVSSAKALQHCEELIQQYNRAEDSICLADSKPLPHQNVTNHVGKAVEDCMRAIIGVLLNLTNDNEWGST KTGEQDGLIGTALNCVLQVPKYLPQEQRFDIRVLGLGLLINLVEYSARNRHCLVNMETSCSFDSSICSGEGDDSLRIGGQVHAVQALVQL FLERERAAQLAESKTDELIKDAPTTQHDKSGEWQETSGEIQWVSTEKTDGTEEKHKKEEEDEELDLNKALQHAGKHMEDCIVASYTALLL -------------------------------------------------------------- >56665_56665_2_MYO1D-WAPAL_MYO1D_chr17_31065270_ENST00000579584_WAPAL_chr10_88233730_ENST00000298767_length(transcript)=6234nt_BP=2018nt GTCTCGGTGTCCCGGCCCCTACAGCGCCCGGCAGCCGCGGCGGGAGGAGCGGAAACTGTCGGGTGCGTCCCGTTCGGAGCCGCGCCGGCC GAGAAGGCGCCGAGGAGCAGCGAGGCGGCCTCTGTCCGGCCCGGACCCGCCGAGCGGCGTGCGCGCCCCCTCCCCGTAGCCTCGCGGCGC GGCCTCGCCCCGGCCCCTCCCGAGCTCATCGCGGGCCCACGGAGCGGCCCCGGAGGCCCGAGCGCGCCCACCTGAGCCCCCGCGCTGGCG CCATGGCGGAGCAGGAGAGCCTGGAATTCGGCAAGGCAGACTTCGTGCTGATGGACACCGTCTCCATGCCCGAGTTCATGGCCAACCTCA GGCTCAGATTTGAAAAAGGGCGCATCTATACGTTCATTGGAGAAGTCGTCGTTTCTGTGAACCCTTACAAGTTGTTGAACATCTATGGAA GAGACACAATTGAGCAGTATAAAGGCCGTGAGCTGTATGAGAGACCGCCTCACCTTTTTGCTATTGCGGATGCTGCTTACAAGGCTATGA AGAGGCGATCAAAAGACACTTGTATTGTGATATCAGGGGAAAGTGGAGCTGGTAAAACGGAAGCCAGTAAGTACATTATGCAGTATATTG CGGCCATCACCAACCCCAGTCAGAGAGCAGAGGTTGAAAGAGTGAAGAATATGTTGCTTAAGTCCAACTGTGTTTTGGAAGCTTTTGGAA ATGCCAAAACCAACCGTAATGACAACTCAAGCAGGTTTGGAAAATACATGGATATCAACTTTGACTTCAAGGGTGACCCTATTGGTGGGC ATATCAATAACTACTTACTAGAAAAGTCTCGAGTGATTGTGCAACAGCCAGGAGAAAGAAGCTTTCATTCTTTCTATCAGCTACTCCAAG GAGGTTCAGAACAAATGCTACGCTCTCTACATCTCCAGAAATCCCTTTCATCCTACAACTATATTCATGTGGGAGCTCAATTAAAGTCTT CTATCAATGATGCTGCCGAATTCAGAGTTGTTGCTGATGCCATGAAAGTCATTGGCTTCAAACCTGAGGAGATCCAAACAGTGTATAAGA TTTTGGCTGCTATTCTGCACTTGGGAAATTTAAAATTTGTAGTAGATGGTGACACGCCTCTTATTGAGAATGGCAAAGTAGTATCTATCA TAGCAGAATTGCTCTCTACTAAGACAGATATGGTTGAGAAAGCCCTTCTTTACCGGACTGTGGCCACAGGCCGTGACATCATTGACAAGC AGCACACAGAACAAGAGGCCAGCTACGGCAGAGACGCCTTTGCCAAGGCAATATATGAGCGCCTTTTTTGTTGGATCGTTACTCGCATCA ATGATATTATTGAGGTCAAGAACTATGACACCACAATCCATGGGAAAAACACTGTTATTGGTGTCTTGGATATCTATGGCTTTGAAATCT TTGACAACAACAGTTTTGAACAATTCTGTATCAATTACTGCAATGAGAAACTGCAGCAGCTATTTATTCAGCTGGTTCTGAAGCAAGAAC AAGAGGAATACCAGCGGGAAGGGATCCCCTGGAAACATATTGACTACTTCAACAATCAGATCATTGTTGACCTCGTGGAGCAACAGCACA AAGGGATCATTGCAATCCTTGATGATGCTTGCATGAATGTCGGCAAAGTCACCGATGAAATGTTTCTTGAAGCACTTAACAGTAAATTGG GCAAACACGCCCATTTTTCCAGCCGAAAGCTCTGTGCCTCAGACAAAATTCTGGAGTTTGATCGAGATTTTCGAATTCGACATTATGCAG GCGATGTAGTCTATTCTGTCATTGGTTTTATTGACAAAAATAAAGATACTTTATTTCAAGATTTCAAGCGCCTTATGTATAACAGTTCAA ATCCTGTGCTCAAGAATATGTGGCCTGAAGGCAAACTGAGCATTACAGAGGTGACCAAGCGACCTCTGACTGCTGCTACCTTGTTTAAGA ATTCTATGATTGCTCTAGTAGACAACCTTGCATCAAAGTCACCCACAAAAGCTGTATATAATGCCAGACATTGGAATCATCCAGATTCAG AAGAACTGCCTGGGCCACCAGTAGTAAAACCTCAGAGTGTCACAGTGAGGCTGTCTTCAAAGGAACCAAATCAAAAAGATGATGGAGTTT TTAAGGCTCCTGCACCACCATCCAAAGTGATAAAAACTGTGACAATACCTACTCAGCCCTACCAAGATATAGTTACTGCACTGAAATGCA GACGAGAAGACAAAGAATTATATACTGTTGTTCAGCACGTGAAGCACTTCAACGATGTTGTAGAATTTGGTGAAAATCAAGAGTTCACTG ATGACATTGAGTACTTGTTAAGTGGCTTAAAGAGCACTCAGCCTCTAAACACACGTTGCCTTAGTGTTATTAGCTTGGCTACTAAATGTG CCATGCCCAGTTTTCGAATGCACCTGAGAGCACATGGGATGGTAGCAATGGTCTTTAAAACCTTGGATGATTCCCAGCACCATCAGAATC TGTCCCTCTGTACAGCTGCCCTCATGTATATACTGAGTAGAGATCGTTTGAACATGGATCTTGATAGAGCTAGCTTAGATCTAATGATTC GACTTTTGGAACTGGAACAAGATGCTTCATCAGCCAAGCTACTGAATGAAAAAGACATGAACAAAATTAAAGAAAAAATCCGAAGGCTCT GTGAAACTGTACACAACAAGCATCTTGATCTAGAAAATATAACGACTGGGCATTTAGCTATGGAGACATTATTATCCCTTACTTCTAAAC GAGCAGGAGACTGGTTTAAAGAAGAACTCCGGCTTTTGGGTGGTCTGGATCATATTGTAGATAAAGTAAAAGAATGTGTGGATCATTTAA GTAGAGATGAGGATGAAGAGAAACTGGTAGCCTCACTATGGGGAGCAGAGAGATGTTTACGAGTTTTAGAAAGTGTAACTGTGCATAATC CCGAAAATCAAAGCTACTTGATAGCATATAAAGATTCCCAACTTATTGTTTCATCAGCTAAAGCATTACAGCATTGTGAAGAACTGATTC AGCAGTACAACCGTGCTGAGGACAGCATATGCTTAGCTGACAGTAAGCCTCTGCCTCACCAGAATGTAACTAACCATGTAGGCAAAGCAG TGGAGGACTGCATGAGGGCCATCATCGGGGTGTTGCTTAATTTAACTAATGATAATGAGTGGGGCAGCACCAAAACAGGAGAGCAGGACG GTCTCATAGGCACAGCGCTGAACTGTGTGCTTCAGGTTCCAAAGTACCTACCTCAGGAGCAGAGATTTGATATTCGAGTGCTGGGCTTAG GTCTGCTGATAAATCTAGTGGAGTATAGTGCTCGGAATCGGCACTGTCTTGTCAACATGGAAACATCGTGCTCTTTTGATTCTTCCATCT GTAGTGGAGAAGGGGATGATAGTTTAAGGATAGGTGGACAAGTTCATGCTGTCCAGGCTTTAGTGCAGCTATTCCTTGAGCGAGAGCGGG CAGCCCAGCTAGCAGAAAGTAAAACAGATGAGTTGATCAAAGATGCTCCCACCACTCAGCATGATAAGAGTGGAGAGTGGCAAGAAACAA GTGGAGAAATACAGTGGGTGTCAACTGAAAAGACTGATGGTACAGAAGAGAAACATAAGAAGGAGGAGGAGGATGAAGAACTTGACCTCA ATAAAGCCCTTCAGCATGCCGGCAAACACATGGAGGATTGCATTGTGGCCTCCTACACAGCACTACTTCTTGGGTGTCTCTGCCAGGAAA GTCCAATCAATGTAACCACTGTGCGGGAATATCTGCCAGAAGGAGACTTTTCAATAATGACAGAGATGCTCAAAAAATTTTTGAGTTTTA TGAATCTCACTTGTGCTGTTGGAACAACTGGCCAGAAATCTATCTCTAGAGTGATTGAATATTTGGAACATTGCTAGCTGCTTTACCTTT GCTTCAGGTGCTCGGTAATGCTGGAGCTATCCTTAGACAAAGAAAAGTCAAGTCATGAAAGAAGTCCTTGAAGATATACCAAGAACATTC ATCAGTATCATTCGTGTTTGGATTTTTAAGGCCACCTGATTTCTTCGTCATGCATTCGGCATTTGCTAAATGACAGTTACTACATCAATC TGCAACTATCAAAAATGAGGGGAAAAGGTTCAGGCTGTTAACAATTCCATGCAGTATTTAAATACATTTACTTTGGCAGAGTTTATACCC TCCCCTTGTTTTCTTGCTTTATTCTGGGCAAGTTTGAAGGGGAAAATTTGTGCTGCTGTTAGTGCAACTGCTGTGTATGTTGAGCCACTG TTGTCATGCCAGCCAGGTGCAAAGGCAGCTTAGCTACTGAGGTAGCGAATGTTCTGAGGACATTCTAGACAACAGCTTAGTTCCTTTTTC AGGCTCATTTGCTTTTGCTTTTTTGTTGAATGATTCCAATCGTAAATAAAGCTTTTAATAATTTTGTGAATTTTTTGGTTGTTGTTCCCT GAACTACTGTCTATATTTAAAATTAGATGGAATCCAAAGATACACGGGATTAATAGTATATTTTTTTATTCTTGATTAGGTTTGGGTTAT TGAACTATTTTTTACTTTTGAGACCACAACCATATTCAATATCATACCATAATGTGTCATAGCTATAGGCACAAGAAAAACAACAGTTTG AGAGAATATTATATAAGATGATGTGCCCTGTTAAAAGGAGGAGGCAAAATAGTCAAACCCAGGGTAGTTTACACTTAATGCTAGGGAGGC TCTTAAAACATTATTAGATTTTGAGGAAAGACTCTCTAGATATATTTTCTAATGTTCAGTACAATAAATATAAGGAAGCTAAAACACCAA TGTGGAATTCCTGTTTCCAGATAACATGTATATTCTTCTATAGAGTGACAGGATCAATTGCATAAGCGCAAAGCCTTAAATTGCTGGTTT AGAGAAGACCCTTTTTTCATTCAGATTCTTTGTTCGTAGAGCAGTTATTTGAAAAACAGTTATGGAACACAAAACATTTTATAGATTTAA TATCATAACATTGCAAATTTTTCTTGTATTATTCACACCACTGGTTATACTTTTTTTTTTCCTTTTTTATTGATTGGGCCTGAATACAGG CTTTCTAGAGATCTTTTTCATTAATACTTTTAAATACCTTTCAGGTAGTTACATCATGTTTCTTCATTGGATTTGTAAAACTTGAAGCCA TAAAAATATTAGTTTGGTGTGTATTGGGGAAAATAGCTAAAAGTCTAATTTTTACCCATTTAGACTTTGTTATTTCCTTGTATAAAGTGA CAAATCGGGGCTCTTGTATCAGTGCCAGCTGTAATGTTTTTAAATGCAGTGGCTGCCTTCTATTGTCTTCCTATTTTTGATAATGCAGAT TGTTGGGAAATCTGTAAGGAAGTAACTGATTCCAGGCAAATTGTTTTCTTCCTTCTACCCACCCCAACCCCTACCCATCACCTTTTAAGA ACATAGTACGCCAGTGTAACGTGGGAACCATTGAGATTGTATTTGCCCTGAGTATTAAAGCTAGCTTAGCAAAATACTTTTAAAAACATA TTGGTAAATGATACCCGTAAAATTAAATTAGTTATATTTTATTTTAAAATGCAAAATACATTGATATTTATTAATCATTGGATTTAGGGA AAGGGACAGATTTTTGGTGAACCTGACTTGTGGCAGATGGTAAGGAATATTATAAAACATTTGGATGAGAACAATCAGGGCGAACTGCAT TTTTCTGTTACACTGGTAATCATTTGAAAATTGATTTACCTCAGTGTTTAACAGTTTTTTGTTTTGTTTTGTTTTTTAAATAATAACTAA TTGTCGAGCACTGATAGAGATGCAGATTTTGGTGGGGGGAGGTGGTGGGGGAGATAATCACTTCACCAACTGCAGTGCATTTGTGTGTTT TTAACCCTCAGAGAACTCTGCATTTTAGGGTACTTGAGGCTGACTTAACTAAAAGTTTTAAAGTAACCTTTTTTCCATTGTAAATATTTC TGTAAATACTACCAATTGGAAATTAGAACAGTAGAGTACTTTTCTGAATCCAATCCTATTTTTATTTTATACAGTATTTCTCAGCTGTGA TCTTTGGAGCAAAAGCCAACGGCAGGAAAAAATAGTTTGTACCAGTTTCATGAAGTATGTCTTTGGGTTTTTGTAAATAATTTTAACTCA >56665_56665_2_MYO1D-WAPAL_MYO1D_chr17_31065270_ENST00000579584_WAPAL_chr10_88233730_ENST00000298767_length(amino acids)=1231AA_BP=589 MSPRAGAMAEQESLEFGKADFVLMDTVSMPEFMANLRLRFEKGRIYTFIGEVVVSVNPYKLLNIYGRDTIEQYKGRELYERPPHLFAIAD AAYKAMKRRSKDTCIVISGESGAGKTEASKYIMQYIAAITNPSQRAEVERVKNMLLKSNCVLEAFGNAKTNRNDNSSRFGKYMDINFDFK GDPIGGHINNYLLEKSRVIVQQPGERSFHSFYQLLQGGSEQMLRSLHLQKSLSSYNYIHVGAQLKSSINDAAEFRVVADAMKVIGFKPEE IQTVYKILAAILHLGNLKFVVDGDTPLIENGKVVSIIAELLSTKTDMVEKALLYRTVATGRDIIDKQHTEQEASYGRDAFAKAIYERLFC WIVTRINDIIEVKNYDTTIHGKNTVIGVLDIYGFEIFDNNSFEQFCINYCNEKLQQLFIQLVLKQEQEEYQREGIPWKHIDYFNNQIIVD LVEQQHKGIIAILDDACMNVGKVTDEMFLEALNSKLGKHAHFSSRKLCASDKILEFDRDFRIRHYAGDVVYSVIGFIDKNKDTLFQDFKR LMYNSSNPVLKNMWPEGKLSITEVTKRPLTAATLFKNSMIALVDNLASKSPTKAVYNARHWNHPDSEELPGPPVVKPQSVTVRLSSKEPN QKDDGVFKAPAPPSKVIKTVTIPTQPYQDIVTALKCRREDKELYTVVQHVKHFNDVVEFGENQEFTDDIEYLLSGLKSTQPLNTRCLSVI SLATKCAMPSFRMHLRAHGMVAMVFKTLDDSQHHQNLSLCTAALMYILSRDRLNMDLDRASLDLMIRLLELEQDASSAKLLNEKDMNKIK EKIRRLCETVHNKHLDLENITTGHLAMETLLSLTSKRAGDWFKEELRLLGGLDHIVDKVKECVDHLSRDEDEEKLVASLWGAERCLRVLE SVTVHNPENQSYLIAYKDSQLIVSSAKALQHCEELIQQYNRAEDSICLADSKPLPHQNVTNHVGKAVEDCMRAIIGVLLNLTNDNEWGST KTGEQDGLIGTALNCVLQVPKYLPQEQRFDIRVLGLGLLINLVEYSARNRHCLVNMETSCSFDSSICSGEGDDSLRIGGQVHAVQALVQL FLERERAAQLAESKTDELIKDAPTTQHDKSGEWQETSGEIQWVSTEKTDGTEEKHKKEEEDEELDLNKALQHAGKHMEDCIVASYTALLL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for MYO1D-WAPAL |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for MYO1D-WAPAL |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for MYO1D-WAPAL |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies